Shinya Yoshida1, Fujiko Someya2, Tetsutaro Yahata3. 1. Department of Rehabilitation, Kanazawa University Hospital, Takaramachi 13-1, Kanazawa, Ishikawa, 920-8641, Japan. yoshi511@med.kanazawa-u.ac.jp. 2. School of Health Sciences, Kanazawa University, Kodatsuno 5-11-80, Kanazawa, Ishikawa, 920-0942, Japan. 3. Department of Rehabilitation, Kanazawa University Hospital, Takaramachi 13-1, Kanazawa, Ishikawa, 920-8641, Japan.
Abstract
INTRODUCTION: High-dose chemotherapy for remission induction can induce cardiac toxicity prior to hematopoietic stem cell transplantation (HSCT). However, the details of cardiac function in patients undergoing HSCT are unclear, particularly during exercise. The aim of present study was to evaluate cardiac output responses to exercise in patients after high-dose chemotherapy before HSCT compared with in age-matched healthy controls. METHODS: Twenty-nine patients before HSCT (age 44.6 ± 15.2 years) and 13 controls (45.8 ± 16.0 years) performed the 6-min walk test (6MWT). Cardiac output (CO), stroke volume (SV), heart rate (HR), and cardiac index (CI) were continuously measured during the 6MWT using the noninvasive thoracic impedance method. RESULTS: No significant difference was observed in the six-minute walk distance (6MD) between the two groups. SV, CO, and CI both at rest and the end of the 6MWT in the patients were significantly lower, compared with the controls, but there was no significant difference in HR. In all subjects, the 6MD was positively correlated with SV, CO, CI, and HR after the 6MWT. CONCLUSION: These findings suggest that cardiac output response to exercise indicates exercise intolerance, which may not be detected by 6MD in patients before HSCT.
INTRODUCTION: High-dose chemotherapy for remission induction can induce cardiac toxicity prior to hematopoietic stem cell transplantation (HSCT). However, the details of cardiac function in patients undergoing HSCT are unclear, particularly during exercise. The aim of present study was to evaluate cardiac output responses to exercise in patients after high-dose chemotherapy before HSCT compared with in age-matched healthy controls. METHODS: Twenty-nine patients before HSCT (age 44.6 ± 15.2 years) and 13 controls (45.8 ± 16.0 years) performed the 6-min walk test (6MWT). Cardiac output (CO), stroke volume (SV), heart rate (HR), and cardiac index (CI) were continuously measured during the 6MWT using the noninvasive thoracic impedance method. RESULTS: No significant difference was observed in the six-minute walk distance (6MD) between the two groups. SV, CO, and CI both at rest and the end of the 6MWT in the patients were significantly lower, compared with the controls, but there was no significant difference in HR. In all subjects, the 6MD was positively correlated with SV, CO, CI, and HR after the 6MWT. CONCLUSION: These findings suggest that cardiac output response to exercise indicates exercise intolerance, which may not be detected by 6MD in patients before HSCT.
Authors: A Charloux; E Lonsdorfer-Wolf; R Richard; E Lampert; M Oswald-Mammosser; B Mettauer; B Geny; J Lonsdorfer Journal: Eur J Appl Physiol Date: 2000-07 Impact factor: 3.078
Authors: K Fujimaki; A Maruta; M Yoshida; R Sakai; J Tanabe; H Koharazawa; F Kodama; S Asahina; M Minamizawa; M Matsuzaki; S Fujisawa; H Kanamori; Y Ishigatsubo Journal: Bone Marrow Transplant Date: 2001-02 Impact factor: 5.483
Authors: C Casanova; B R Celli; P Barria; A Casas; C Cote; J P de Torres; J Jardim; M V Lopez; J M Marin; M Montes de Oca; V Pinto-Plata; A Aguirre-Jaime Journal: Eur Respir J Date: 2010-06-04 Impact factor: 16.671
Authors: Mark J Haykowsky; Peter H Brubaker; Jerry M John; Kathryn P Stewart; Timothy M Morgan; Dalane W Kitzman Journal: J Am Coll Cardiol Date: 2011-07-12 Impact factor: 24.094
Authors: Muzaffar H Qazilbash; Ali Imran Amjad; Suhail Qureshi; Sofia R Qureshi; Rima M Saliba; Ziad U Khan; Chitra Hosing; Sergio A Giralt; Marcos J De Lima; Uday R Popat; Syed W Yusuf; Richard E Champlin Journal: Biol Blood Marrow Transplant Date: 2009-08-03 Impact factor: 5.742
Authors: Ana Luiza Machado Dias; Mateus Camaroti Laterza; Pedro Augusto de Carvalho Mira; Isabelle Magalhães Guedes Freitas; Patrícia Fernandes Trevizan; Daniel Godoy Martinez; Leonardo Barbosa de Almeida Journal: Support Care Cancer Date: 2020-11-27 Impact factor: 3.603
Authors: Daniel Santa Mina; Lianne B Dolan; Jeffrey H Lipton; Darren Au; Encarna Camacho Pérez; Alyssa Franzese; Shabbir M H Alibhai; Jennifer M Jones; Eugene Chang Journal: J Clin Med Date: 2020-06-14 Impact factor: 4.241